Medication treatment follow-up

Psychotropic medicines, including antidepressants, anti-anxiety drugs, antipsychotics, mood stabilisers and psychostimulants, act on brain neurotransmitters such as serotonin, dopamine, noradrenaline and GABA to modulate the neural circuits of mood, anxiety and thought. Prescribing a psychotropic drug is a delicate medical act requiring close clinical monitoring to assess the balance of benefits and risks and adjust the course of treatment over time.

At regular follow-up consultations, the doctor assesses the clinical effectiveness of the prescribed drugs, checks for possible side effects such as sedation, weight gain, metabolic disturbances or tremor, and monitors biological tolerance through regular blood tests, including lithium levels and kidney or liver function. They explain how long the drugs take to work, often two to four weeks for antidepressants, to prevent premature discontinuation due to impatience.

Rigorous medical follow-up prevents habituation to benzodiazepine anti-anxiety medication by strictly limiting the duration of prescribing. Once lasting psychological stability has been achieved, the psychiatrist plans a very gradual reduction protocol, or cross-tapering, to avoid rebound effects or abrupt withdrawal syndromes, while maintaining a trusting, reassuring dialogue.

Medication alone does not resolve psychological conflicts or life traumas: it reduces acute suffering to a tolerable level so that the person can once again engage in psychotherapeutic reflection. Psychopharmacological follow-up always forms part of comprehensive care that respects the person’s dignity.

Successful medication-based care rests on an alliance of trust. Patients are encouraged to express all their doubts about treatment, reservations and experienced adverse effects without fear, allowing the practitioner to adapt the protocol flexibly with full respect for informed consent.